Novo Nordisk
NVO
#22
Rank
S$536.88 B
Marketcap
$115.18
Share price
-17.83%
Change (1 day)
-16.09%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Net assets

Net assets on the balance sheet as of September 2024 : S$24.46 Billion

According to Novo Nordisk's latest financial reports the company has S$24.46 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novo Nordisk - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$S$20.84 B29.32%
2022-12-31$S$16.11 B10.69%
2021-12-31$S$14.56 B5.15%
2020-12-31$S$13.84 B18.95%
2019-12-31$S$11.64 B7.29%
2018-12-31$S$10.85 B1.02%
2017-12-31$S$10.74 B15.79%
2016-12-31$S$9.27 B-4.72%
2015-12-31$S$9.73 B11.96%
2014-12-31$S$8.69 B-12.91%
2013-12-31$S$9.98 B13.33%
2012-12-31$S$8.81 B4.29%
2011-12-31$S$8.44 B-0.58%
2010-12-31$S$8.49 B-12.07%
2009-12-31$S$9.66 B8.86%
2008-12-31$S$8.87 B-2.17%
2007-12-31$S$9.07 B10.78%
2006-12-31$S$8.19 B12.62%
2005-12-31$S$7.27 B-8.22%
2004-12-31$S$7.92 B9.04%
2003-12-31$S$7.26 B29.95%
2002-12-31$S$5.59 B6.86%
2001-12-31$S$5.23 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
S$125.42 B 412.66%๐Ÿ‡บ๐Ÿ‡ธ USA
S$19.40 B-20.68%๐Ÿ‡บ๐Ÿ‡ธ USA
S$23.30 B-4.73%๐Ÿ‡บ๐Ÿ‡ธ USA
S$106.03 B 333.42%๐Ÿ‡ซ๐Ÿ‡ท France